Since 1982, the Industrial Research Institute (IRI) has undertaken an annual survey of R&D spending expectations among R&D-and innovation-focused companies. Typically, the survey asks R&D leaders about their actual activity and budgets in the past year and their expectations and projections for the coming year. The publication of those results in the January issue of RTM has become an annual event.
than half (57%) expecting to see their R&D budgets improve over the next five years ( Figure 3 ). The remaining survey respondents expect to see their R&D budgets decline (11%) or stay the same (31%) as they have in 2015.
Most survey respondents (75%) stated that they basically held to their formal R&D budgets in 2014, while some (15%) overspent their budgets and a few (10%) underspent their R&D budgets. Similar results were obtained from the researchers when they were asked about their current 2015 R&D budgets. These research budgets however were noted as being restricted, since nearly two thirds of the researchers stated they were limited in what research they could perform by their tight budgets-no one stated that they had excess funds, even though they might have underspent their budgets. Despite their budgets, or lack thereof, most researchers we surveyed indicated that their R&D was successful in 2014. Only a handful (6%) noted that their R&D was unsuccessful.
U.S. R&D Improves, But with Limitations U.S. researchers-all those in government, industry, and academic labs-struggled throughout 2015 with a host of uncertainties to understand how to plan for their 2016 R&D budgets. And as we close out 2015, many of those uncertainties have not been allayed. The overriding factor in 2015 was the global economy and its effects on all areas of the R&D environment, what measures might be employed to support it, and how effective those measures might be. All types of factors that bear upon the R&D arena have become involved-politics, economics, technologies, global trade, regulatory, and more.
For 2016, total U.S. R&D spending is expected to increase by 3.5% to $507.8 billion or a 2.0% increase after accounting for 2016's expected 1.5% inflation rate. This is the third consecutive year of positive increases following flat R&D growth in the recession-recovery years. [Still, a number of factors combined to create a weaker than expected environment for strong fiscal growth.] However, the U.S. fares better than most other overseas economies. This strength . . . can be attributed to the U.S.'s strong energy resources and the potential for both short-and long-term improvements.
[One large source of continuing uncertainty is fluctuating federal funding levels. As this report goes to press, the US Congress has yet to finalize a budget for FY2016. Just how the budget and negotiations around it will affect R&D spending remains to be seen, although federal R&D allocations are likely to be larger than was initially anticipated in the drafting of this report.]
The Global Researcher
Effective research and development has many different aspects and components, including innovation, funding, technologies, and the scientists and engineers that make up the R&D staff. How those researchers feel about their work and their R&D environment makes up this section of the 2016 Global R&D Funding Forecast.
Innovation is considered one of those key aspects that drives the development of new and successful product development. In the various surveys that we performed to create this report, one of the questions we asked researchers was if the level of innovation within their organization was adequate. Surprisingly, more than half (56%) stated that the level of innovation within their organization was NOT adequate. When the researchers were asked about the innovativeness of their own personal work, their company, industry, and country, more than 40% of the survey respondents stated that they were personally very innovative, while only ranking their group, organization, organization's R&D, competitors' R&D, industry's, and country's innovativeness in the 18% to 26% range for being very competitive. Looking at a composite of these rankings, with 1.0 being very innovative and 5.0 being not innovative at all, the average rankings reveal the disparities between the different groups ( Figure 4 ).
The R&D Budget
Nearly two-thirds of the researchers we surveyed stated that they had larger R&D budgets in 2014 than they did in 2013 by an average of about 7%. About 20% stated they had similar budgets and the remaining researchers (16%) stated they had smaller budgets in 2014 than they had in 2013, again by about 7%. Most of those researchers (75%) stated that they held to their budgets, while about 15% overspent their budgets and the remaining 10% underspent their budgets.
While the majority of these researchers had larger budgets in 2014 than they had in 2013, they still stated that they were limited in what they could do by a shortage of R&D funds. Most of the researchers (74%) stated that their R&D in 2014 was successful. Only 6% of the survey respondents stated that their R&D was unsuccessful-only 2% said it was extremely unsuccessful, while the other 4% said it was only slightly unsuccessful.
The ratios were quite similar when looking at the researchers' 2015 versus 2014 R&D budgets. Again, nearly two-thirds (62%) said they had larger R&D budgets in 2015 than they had in 2014, 20% had similar budgets and 15% had smaller R&D budgets in 2015 than they had in 2014. The larger R&D budgets for 2015 averaged about 6% larger, while the reduced R&D budgets for 2015 were about 5% smaller. Very few researchers (3%) had budgets that were more than 10% smaller than in 2014 while a considerable number of researchers (12%) stated that their 2015 R&D budgets were more than 10% larger than in 2014.
Looking at how researchers distribute their R&D budgets, the largest portion of the R&D pie is dedicated to staff salaries (33%) ( Figure 5 ). This is consistent with R&D funding reports we've created in the past. Capital spending takes up the next largest share at 18%, and this accounts for new research lab designs, construction and renovations; new large instrumentation and equipment purchases; and the creation of specialized testing structures and systems. Often, the capital expenditures assigned to the organization's R&D budget are of a lower scale, while larger structures and systems are assigned to capital budgets in the operational side of the organization. In that regard, the cost for a new NMR system might be allocated to the R&D budget, while the cost of a relatively massive structure for housing that same NMR would be allocated to the organization's operations budget. The bulk of the remaining R&D budget is comprised of materials (15%), supplies and consumables (11%), overhead including utilities, maintenance, and support (12%), and outsourcing (6%). A 5% "other" category for the R&D budget can accommodate things like licensing, legal fees, transportation, training, recruitment, and emergency activities and systems.
Finding the Money
Researchers . . . get funding for their work from a variety of areas ( Figure 6 ). The largest fraction of researchers get funding for their research operations from internal sources, be that The second largest source of funds (36%) comes from external grants, such as those that might come from the NIH or NSF for academics or biopharmaceutical researchers, or from the DOD or National Institute of Standards and Technology (NIST) for industrial or aerospace organizations.
R&D funding from external contracts (32% of the survey responses) is the third largest source of funds for R&D organizations. These contracts include the work funded by the federal government to industrial R&D organizations and between industrial companies for contract research work. Crowd sourcing is a popular method of obtaining research funding, but still the smallest category of funding sources (6%).
Finding the money for R&D is important for creating a strong, innovative R&D environment. The largest component of an organization's R&D budget is that part dedicated to scientists/engineers salaries (33% of the overall budget). The highest importance within the R&D environment, according to our survey, is that component responsible for attracting and maintaining an adequate R&D staffnearly two-thirds of the researchers surveyed indicated this component as having the highest importance for their R&D. Money is obviously just one component for maintaining and attracting researchers, but it is likely the most important component. Tied closely to creating a strong research staff is the creating of an innovation culture within the R&D organization, according to our survey results.
As a carry-over from the lessons learned in the Great Recession of 2008-2009, many R&D organizations still run a lean operation. "Our biggest concern for our 2016 R&D budget is a decreased R&D budget due to limited or declining sales," says one researcher. "Our biggest concern for our 2016 R&D budget is our business performance, which is driven by currency exchange rates and soft industrial markets," says another researcher. Economics (as applied to funding R&D operations) and, to a much lesser degree, R&D staffing dominated the concerns of our survey respondents.
IRI's Sea Change Index and Historical Trends
This portion of the analysis was conducted exclusively by IRI and does not appear in other editions of the GFF study.
The collaboration between IRI and R&D Magazine involved distributing three separate surveys over a period of several months in mid-2015, each survey focusing on a different aspect of R&D spending and timeframes. The historic data reported in this portion of the report was gathered from the third and final survey and included 191 responses, of which 100 were from organizations that typically spend $0.5 million or more on R&D each year, the population from which IRI's historical data has been drawn ( Table 1) . As a result of the different mix of respondents accessed by the collaboration, this year's survey is heavily biased towards companies spending between $0.5 million and $50 million on R&D in the coming year (Table 2) , with 80 of the 100 responding companies investing in R&D in this range. 
Historic Data
Historic data is invaluable as it allows the ability to visualize trends over time that may reveal more about R&D spending expectations than that provided by a one-year snapshot. To maintain the historic data typically gathered by IRI, responses were analyzed through the lens of IRI's proprietary Sea Change Index. This index is calculated by subtracting the number of respondents who anticipate a negative change from the number who anticipate a positive change in spending for each category and then normalizing the data to a 100-point scale by dividing the difference by the number of responses. The range of the index varies from À100 to þ100 percent. It should be noted that the index does not measure actual growth rates; it measures sentiment (optimism vs. pessimism). Survey responses indicating zero expectations of change are not considered a part of the analysis; only those expecting an increase or a decrease are included. Likewise, it should be understood that sentiment, both positive and negative, can be moderated when the bulk of responses report expectations of little to no change. In this year's report, respondents expecting little to no change accounted for approximately 40-60 percent of responses, depending on the question, allowing the sentiment obtained by this analysis to be considered relevant and reliable.
Data for this year's R&D spending expectations reveals a strong upswing in positive sentiment regarding next year's investment levels (Figure 7) . Respondents show the most growth in positive expectations for total R&D spending of any IRI survey in the last 15 years. This year's sea change score for total R&D investment expectations revealed a reading of þ43 percent, up from last year's reading of À3 percent. While this does not represent the percentage of growth to be expected, it does indicate that there is high optimism regarding total R&D spending. Other categories showed similar, though less startling gains. Capital spending moved from À7 to þ28 percent, and the R&D/sales ratio shifted from À6 to þ13.
The data also show optimism across spending categories, the most significant change coming from the historically negative categories of Support of Existing Businesses (labeled "Technical Service" in the survey) and Directed Basic Research, both of which moved significantly upward from last year's pessimistic reading to one showing moderate optimism moving into 2016 (Figure 8) . Support for new business projects (labeled "Development" in the survey), showed one of the highest readings (þ41 percent) in the survey's history, topped only by 2001's surge to þ44 percent.
This optimism seems to be more moderated, however, in several collaboration categories. While sentiment regarding investment in overall R&D is on the rise, and and federal laboratories, with moderate increases in these indexes from last year's somewhat pessimistic assessments.
Industry Sector Trends
In an effort to capture R&D spending expectations in more detail, the survey asks for information about participants' industry segment; the data are then analyzed by industry segment to examine where the biggest changes are taking place and which factors are most affecting particular industries. To be included in the segmentation data, an industry sector must be represented by at least five respondents. In this year's instance, inclusion in the segmentation analysis requires five or more responses in the third survey, the specific source of the data for this analysis. This year, there were nine qualifying industrial segments: academia, healthcare/medical devices, aerospace/defense, chemicals, FIGURE 11. Spending on R&D collaboration by industry electronics, R&D services, biotech, federal labs, and food. The data on spending across these industrial segments largely align with the overall survey results, with a few exceptions (Figure 10) .
Across spending categories, trends for individual industries are in accord with the overall data, except for capital spending in academia and federal laboratories, which show negative and neutral tendencies, respectively. The targeted R&D/sales ratio overall was only slightly optimistic in the aggregated data, but in the segmentation data, aerospace/ defense and healthcare companies show negative sentiment in this category. Two categories stood out in the full data as significantly more optimistic than previous iterations of this survey, Support of Existing Business and Directed Basic Research. This analysis holds true in the segmentation data, as well, for all sectors except academia and federal labs. Academia shows neutral sentiment (0 percent tendency) for the former category and a mildly optimistic tendency (þ10 percent) for the latter. Federal lab respondents are neutral on both categories.
In the collaboration categories (Figure 11 ), analysis across industrial segments largely aligns with the overall view, with only two minor exceptions. Healthcare/medical device companies reported neutral sentiment towards participation in consortia for university research, a slight improvement in sentiment from last year. Aerospace/defense companies were also neutral toward grants/contracts for university R&D, the category that exhibited the most dramatic upswing on the overall sea change index.
Segmentation can offer some interesting perspectives on the overall data. Some trends appear to make a stronger showing when data are segmented by industry, skewing more strongly either positive or negative in the industries analyzed. For instance, sentiment regarding capital spending is highly optimistic in the overall data, but three of the nine segmented industries expect no change in this area, and one (academia) expects a decline. Sometimes the data can reveal a weak spot in a major trend. One example is overall professional hiring, which is strongly rising in the overall view but shows a decline for US federal labs (in this case, for the second year running). Likewise, participants are increasingly optimistic about support for new business projects overall, but federal labs show a mild decline in sentiment for this category. One remarkable standout in the data is the very strong showing of food companies, which reported expectations of moderate to strong growth in every category except one (Acquisitions of Technology through M&A).
Summary
Overall, R&D managers are much more optimistic about R&D investment growth going into 2016 than they were in last year's survey. New business projects remain a key driver of investment, but collaboration activities, which had been strong, are this year a small weak spot, but still positive overall; this year, all categories reported a sea change index reading above 0.
Hiring expectations for R&D professionals appear to be continuing their growth across almost every industry segment with the exception of federal labs, whose budgets were uncertain at the time surveys were distributed. Global investment patterns also appear to be stable. In stark contrast to last year's neutral to pessimistic outlook, this year's respondents expressed record optimism regarding R&D spending. However, economic fundamentals remain ambivalent and, with the federal budget still to be negotiated, it remains to be seen whether that optimism will be supported by events.
